zoledronic acid has been researched along with Liver Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angus, PW; Byth, K; Crawford, BA; Handelsman, DJ; Kam, C; McCaughan, GW; Pavlovic, J | 1 |
1 trial(s) available for zoledronic acid and Liver Failure
| Article | Year |
|---|---|
Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial.
Topics: Bone Density; Bone Density Conservation Agents; Chronic Disease; Diphosphonates; Double-Blind Method; Follow-Up Studies; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Hypocalcemia; Imidazoles; Infusions, Intravenous; Liver Failure; Liver Transplantation; Osteoporosis; Parathyroid Hormone; Zoledronic Acid | 2006 |
1 other study(ies) available for zoledronic acid and Liver Failure
| Article | Year |
|---|---|
Summaries for patients. Zolendronic acid prevents bone loss after liver transplantation.
Topics: Bone Density; Bone Density Conservation Agents; Chronic Disease; Diphosphonates; Double-Blind Method; Follow-Up Studies; Humans; Imidazoles; Infusions, Intravenous; Liver Failure; Liver Transplantation; Osteoporosis; Zoledronic Acid | 2006 |